NCT06269367

Brief Summary

An affordable and easy to use gait-assistive device for stroke survivors to use at home is yet to be developed. This study is intended to modify the current design of the NewGait device to specifically work for stroke survivors based on feedback from patients and clinicians. Consequently, conducting a short-term biomechanical gait study is planned to determine the usability and functionality of the NewGait device compared to other comparative devices.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Apr 2024

Shorter than P25 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 13, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 21, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

April 1, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 9, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 9, 2024

Completed
1 year until next milestone

Results Posted

Study results publicly available

December 23, 2025

Completed
Last Updated

December 23, 2025

Status Verified

December 1, 2025

Enrollment Period

8 months

First QC Date

February 13, 2024

Results QC Date

December 5, 2025

Last Update Submit

December 5, 2025

Conditions

Keywords

gait trainingbalanceStroke survivors

Outcome Measures

Primary Outcomes (2)

  • Gait Speed

    Changes in gait speed (from baseline) as measured using the 10 Meter Walk Test between the experimental (NewGait) and control conditions. Participants were timed during the 10 Meter Walk Test to determine their self-selected gait speed while walking overground in a hallway. In this test, participants walked down a 14 meter walkway, and a stopwatch was used to time how long it took participants to cross the intermediate 10 meter distance. The baseline measure for the first device was taken immediately prior to the intervention. Participants then wore the first device, and the during-training measure was taken immediately. After this, participants received training with the device for about 15 minutes, following which, the device was removed and the post-intervention measure was taken immediately for the first device. Participants then rested for 20-30 minutes. This entire process was repeated with the second device. All measures were obtained on the same day.

    Up to 2 hours

  • Ankle Muscle Activation

    Changes in ankle muscle activation of the leg muscles as measured using surface electromyography between the experimental (NewGait) and control conditions. Muscle activation ranges from 0 to no upper limit, and higher activation meant that the muscle was being used more. The baseline measure for the first device was taken immediately prior to the intervention. Participants then wore the first device, and the during-training measure was taken immediately. After this, participants received training with the device for about 15 minutes, following which, the device was removed, and the post-intervention measure was taken immediately for the first device. Participants then rested for 20-30 minutes. This entire process was repeated with the second device. All measures were obtained on the same day.

    Up to 2 hours

Secondary Outcomes (1)

  • Changes in Paretic Leg Propulsive Force

    Up to 2 hours

Other Outcomes (3)

  • Changes in Paretic Leg Loading (i.e., Vertical Ground Reaction Force)

    Up to 2 hours

  • Changes in Other Lower Extremity Muscle Activation

    Up to 2 hours

  • Muscle Coordination

    Up to 2 hours

Study Arms (2)

NewGait

EXPERIMENTAL

Participants will put on the NewGait device and walk on the treadmill and overground. Participants may receive biofeedback of their gait patterns to engage them in the training.

Other: NewGait

Control

OTHER

Participants will put on the Control device and walk on the treadmill and over ground. Participants may receive biofeedback of their gait patterns to engage them in the training.

Other: Control wearable limb orthotic device

Interventions

NewGaitOTHER

wearable limb orthotic device

NewGait

wearable limb orthotic device

Control

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Unilateral cortical or subcortical stroke
  • Chronic stroke (≥ 6 months) At least 6 months following their first unilateral stroke
  • Able to walk independently with/without assistive devices for 5-10 mins (\~150m)
  • No significant cognitive deficits as determined by the Mini Mental State Examination (MMSE) score (score≥ 22)

You may not qualify if:

  • Cerebellar stroke
  • Traumatic or vascular brain injury
  • History of unstable heart condition, uncontrolled diabetes/hypertension
  • History of a recent lower-extremity trauma or fracture
  • History of a recent significant orthopedic or neurological conditions that could limit walking ability (e.g., multiple sclerosis, total knee replacement)
  • Documented history of significant spatial neglect
  • ankle joint contractures or significant spasticity in the lower limbs
  • History of a recent Botulinum Toxin (Botox) injection to the lower-extremity muscles (≤ 3 months)
  • Pregnant or actively planning to become pregnant (self-reported)- Inability to communicate or unable to consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Physical Medicine & Rehabilitation 325 E Eisenhower Pkwy Suite 3011

Ann Arbor, Michigan, 48108, United States

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Results Point of Contact

Title
Chandramouli Krishnan
Organization
University of Michigan

Study Officials

  • Chandramouli Krishnan, PT, PhD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Participants will be randomly assigned to the two device interventions but will receive both interventions.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Physical Medicine and Rehabilitation

Study Record Dates

First Submitted

February 13, 2024

First Posted

February 21, 2024

Study Start

April 1, 2024

Primary Completion

December 9, 2024

Study Completion

December 9, 2024

Last Updated

December 23, 2025

Results First Posted

December 23, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations